loading
Kybella is an injectable treatment made of synthetic deoxycholic acid that dissolves small pockets of fat. It is FDA-approved for adults with moderate to severe fullness beneath the chin—the so-called double chin—and works by destroying fat cells at the injection site.
Kybella addresses submental fullness—the pocket of fat beneath the chin that can persist even when weight and habits are stable. Unlike liposuction it involves no incisions, and unlike device-based fat freezing it works through a series of small injections. Treatment is delivered over multiple sessions, and the change it produces is a cleaner transition between the chin and the neck rather than a dramatic reshaping of the lower face.
The injections act only on subcutaneous fat at the treated spots. They cannot tighten loose skin, and they do not help when fullness under the chin comes mostly from skin laxity, muscle banding, salivary glands, or bone structure—distinctions a clinician should assess before treatment. Some practices also use the drug off-label in small body areas, but that use falls outside the approved indication and deserves an explicitly cautious discussion. It is not a weight-loss treatment.
The active ingredient is synthetic deoxycholic acid, a molecule the body naturally produces to help break down dietary fat. Injected into the fat layer beneath the chin, it disrupts the membranes of fat cells; the destroyed cells are then cleared gradually by the body's own processes over the following weeks. Because those cells are removed rather than shrunken, they can no longer store fat—though the remaining cells still can, which is why a stable weight matters.
At the visit, the provider assesses the area, marks a grid of injection points, and usually numbs the skin with ice, topical anesthetic, or local injections. The treatment itself is a series of small injections and typically takes well under half an hour; stinging or burning during and shortly after injection is common, and swelling begins almost immediately. Most people need more than one session, spaced at least about a month apart, with the visible change developing gradually between sessions.
A typical candidate is an adult with moderate to severe fullness under the chin, at a reasonably stable weight, who prefers injections over surgery and can accept both a visible swelling period and a multi-session timeline. A worthwhile consultation should establish whether the fullness is actually fat rather than loose skin or deeper anatomy, how many sessions may be reasonable, whether alternatives such as liposuction or skin-tightening approaches would suit better, and what a realistic outcome looks like.
It is not appropriate for everyone. Treatment should not be performed where there is an infection at the planned injection sites, and its safety during pregnancy or breastfeeding has not been established, so it is generally deferred. Tell the clinician about any difficulty swallowing, prior surgery or cosmetic treatment in the chin and neck, bleeding problems or blood-thinning medication, and any other medical conditions in the area; these details shape whether—and how—treatment can proceed safely.
Swelling is the defining part of recovery and should be planned for honestly: the area under the chin often looks noticeably puffy for one to two weeks, frequently most dramatic after the first session, and some fullness can linger longer. Bruising, pain, redness, firmness, and numbness are also common, and numbness can persist for several weeks. Most people return to routine activities quickly, but the treated area rarely looks camera-ready right away.
Less common complications include injury to the marginal mandibular nerve, which can cause an uneven smile or temporary facial muscle weakness that usually resolves over weeks to months; difficulty swallowing; and, if the drug is placed too superficially or outside the fat layer, skin ulceration or tissue damage. Because the neck contains structures that must be avoided, this procedure belongs in a licensed medical setting with a physician trained in the local anatomy—and off-label body-area injections carry a less established risk profile.
Contact the treating physician promptly if you notice an uneven smile or facial weakness, trouble swallowing, severe or worsening pain, skin breakdown or color change at the injection sites, or swelling that keeps increasing after the first several days. This article is general information only; it is not medical advice and cannot replace an in-person consultation and assessment with a qualified clinician.